Retatrutide is a synthetic peptide examined in laboratory models as a triple agonist at GLP-1, GIP, and glucagon receptors. Research has explored its receptor interactions in studies investigating metabolic signaling, energy expenditure pathways, and adipose tissue regulation in cellular and animal models. Additional testing areas include examination of appetite-related mechanisms and glucose homeostasis in vitro. For research use only. Not for human consumption.